November 26, 2021
Canon Medical signals its support for a multicenter ultrasound liver evaluation and assessment study.
"Otawara, Tochigi Prefecture, Japan, 26 November 2021 - Canon Medical
announced today its support for the iLEAD (innovative Liver, Elasticity,
Attenuation and Dispersion) study, an international multicenter study
aiming to evaluate quantitative ultrasound imaging tools against liver
biopsy (the current clinical gold standard), available on the Aplio Liver
Package for the assessment of Steatosis, Fibrosis, and Inflammation in the
clinical environment."